Max Robotics — Global Service Robot Directory + US Certification

About

Yanbing Zhou is a prominent surgical oncologist whose research sits at the intersection of minimally invasive surgery and colorectal cancer treatment. Working in an era of rapid technological advancement in operative techniques, Zhou has made significant contributions to understanding the comparative outcomes of robotic and laparoscopic approaches for rectal cancer management. His landmark 2025 study examining 3-year locoregional recurrence rates in middle and low rectal cancer patients undergoing robotic versus conventional laparoscopic surgery has already garnered 79 citations, reflecting the immediate and widespread impact of his work on a critically debated question in colorectal surgery. This research addresses a genuine gap in the field — the long-standing absence of robust long-term oncological outcome data for robotic rectal surgery — and provides surgeons and oncologists with meaningful evidence to guide clinical decision-making. Zhou's focus on rigorously evaluating emerging surgical technologies against established standards demonstrates a commitment to evidence-based practice. His work is shaping how surgeons worldwide approach one of the most technically demanding procedures in colorectal oncology, making him an increasingly influential voice in the minimally invasive surgery community.